CAS
CORT icon

Coppell Advisory Solutions’s Corcept Therapeutics CORT Stock Holding History

Coppell Advisory Solutions’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
+962
New +$58.1K 0.02% 371
2026
Q1 		– Sell
-44,745
Closed -$3.14M – 68
2025
Q4 		$3.14M Buy
44,745
+4,644
+12% +$365K 0.31% 66
2025
Q3 		$3.36M Buy
40,101
+8,486
+27% +$614K 0.36% 54
2025
Q2 		$2.31M Buy
31,615
+14,305
+83% +$1.04M 0.27% 70
2025
Q1 		$1.27M Buy
17,310
+14,590
+536% +$888K 0.18% 128
2024
Q4 		$138K Buy
2,720
+1,586
+140% +$83.1K 0.02% 353
2024
Q3 		$49.8K Buy
1,134
+1,130
+28,250% +$40.2K 0.01% 555
2024
Q2 		$130 Buy
+4
New +$110 ﹤0.01% 1689
2023
Q4 		$1.04K Buy
+32
New +$879 ﹤0.01% 1408

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Coppell Advisory Solutions's CORT Position: Q2 2026 in Review

Coppell Advisory Solutions opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 962 shares worth $289K. The stake represents 0.02% of the portfolio and ranks #371 among its holdings. This is a return to the name: Coppell Advisory Solutions previously reported a position in CORT as recently as Q4 2025.

Coppell Advisory Solutions first reported a position in CORT in Q4 2023 and has held it in 9 quarters since. The position peaked at $3.36M in Q3 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Coppell Advisory Solutions held 962 shares of Corcept Therapeutics worth $289K as of Q2 2026.
  • Corcept Therapeutics was a new Coppell Advisory Solutions position in Q2 2026.
  • Corcept Therapeutics made up 0.02% of Coppell Advisory Solutions's portfolio in Q2 2026, its #371 holding.
  • Coppell Advisory Solutions first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • Coppell Advisory Solutions's Corcept Therapeutics position peaked at $3.36M in Q3 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Coppell Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.